Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > nsclc > bronchioloalveolar carcinoma (bac)

Bronchioloalveolar Carcinoma (BAC)

BAC - General Information & Epidemiology
BAC - Pathology & Diagnostic Dilemmas
Treatment of BAC
BAC - Clinical Trials

BAC - General Information & Epidemiology

Epidemiology of Bronchioloalveolar Carcinoma Over the Past Two Decades: Analysis of the SEER Database (PubMed)
Abstract of a study published in the August 2004 issue of Lung Cancer that describes the incidence, demographics, and overall survival of BAC patients as compared to other NSCLC types over the past two decades (1979-1998). [8/04]

Prognosis & Recurrence Patterns in Bronchioloalveolar Carcinoma (FindArticles.com)
Yung-Yang Liu et al.
v. 118 CHEST (October 2000): 940-947
Full text article analyzing the initial radiographic findings, TNM stagings, surgical types, and radiologic features of recurrence, and correlate them with patient survival. Concludes that patients with localized, early stage BAC who underwent curative surgery had a better survival. Patients with localized recurrence after the initial surgery warranted a second resection. Those with a diffuse radiologic pattern of recurrence and/or early recurrence had a worse prognosis. [10/00]

BAC & Prognosis - Recent MEDLINE Abstracts

LUNG-BAC (Association of Cancer Online Resources)
Online discussion group for BAC patients, families and caregivers.

BAC Study - You Can Participate! (Harvard School of Public Health)
Research study to investigate the nature and cause of bronchioloalveolar carcinoma (BAC) with the aim of developing prevention measures and more effective treatments for this rare type of lung cancer. If you have been diagnosed with BAC or adenocarcinoma with "BAC features," you may be eligible to participate. A detailed description of the study is available online. Additional information may be obtained by contacting the study coordinator, Emily Logan, by e-mail: elogan@hsph.harvard.edu or by phone: 617-432-1261. [n.b. Study funded by The Lung Cancer Online Foundation.]



 

BAC - Pathology & Diagnostic Dilemmas

BAC Pathology - Recent MEDLINE Abstracts (PubMed)

Bronchioloalveolar Carcinoma Masquerading as Pneumonia (cancernetwork.com)
by Collette M. Hodges, RN, and Gregory P. Kalemkerian, MD
20, no.7 Primary Care & Cancer (July/August 2000)
Describes bronchioloalveolar carcinoma (BAC), including its epidemiology and etiology, clinical presentation, radiographic features, pathology, diagnosis and staging, treatment and prognosis, and case reports. Aimed at physicians. Registration required for free access to cancernetwork.com. [8/00]

Fine-needle Aspiration Biopsy of Bronchioloalveolar Carcinoma (PubMed)
Abstract of a study evaluating the accuracy of the cytologic diagnosis of bronchioloalveolar carcinoma (BAC) by fine-needle aspiration biopsy (FNAB). [2/01]



 

Treatment of BAC

Treatment Options for Bronchioloalveolar Carcinoma (BAC) (Medscape)
Vincent Miller, MD, describes the various forms of BAC and recommends treatment options. Aimed at health care professionals. Registration required for free access to Medscape. [9/03]

Bronchioloalveolar Carcinoma (PubMed)
Abstract of a study published in the June 15, 2004 issue of Clinical Cancer Research that reviews recent incidence and treatment data in bronchioloalveolar carcinoma (BAC). Presents clinical data and preliminary study results to suggest that BAC provides a useful model for studying predictive markers of epidermal growth factor receptor (EGFR) inhibition. [6/04]

Gefitinib (Iressa; ZD1839) Therapy for Advanced BAC (ASCO)
Abstract of a study presented at the 2004 ASCO annual meeting that found gefitinib is active as a single agent in both untreated and previously treated patients with advanced bronchioloalveolar carcinoma (BAC). [6/04]

New Drug Shows Promise in Treating Patients with BAC (People Living With Cancer)
Reports on a Phase II study presented at the 2003 ASCO annual meeting that found the targeted drug erlotinib (Tarceva) showed encouraging results in patients with BAC. In 30 patients with BAC who had been treated with erlotinib for one month or more, eight (27%) responded to the drug. Researchers also found that erlotinib was more effective in patients who had never smoked. [5/03]

Asymptomatic Recurrent Bronchioloalveolar Adenocarcinoma? (Medscape)
Discusses BAC and its characteristics. Addresses the issue of treatment for asymptomatic recurrence Registration required for free access to Medscape. [1/02]

Frequent EGFR Mutations in Noninvasive Bronchioloalveolar Carcinoma (PubMed)
Abstract of an article published in the December 13, 2005 issue of the Int J Cancer that reports on the frequent occurrence of epidermal growth factor receptor (EGFR) gene mutations in noninvasive bronchioloalveolar carcinoma (BAC). [12/05]

BAC & Treatment with EGFR Inhibitors (Iressa & Tarceva) - Recent MEDLINE Abstracts

BAC & Surgery - Recent MEDLINE Abstracts

BAC & Lung Transplantation - Recent MEDLINE Abstracts

 



 

BAC - Clinical Trials

BAC (or Adenocarcinoma w/BAC Features) Clinical Trial (Millennium Pharmaceuticals)




 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 30-Nov-2007
Karen Parles, MLS Editor